Effects of Vitamin E on Neonatal Hyperbilirubinemia in Preterm Newborns

Area of Science:

• Neonatal Medicine
• Pediatric Gastroenterology
• Nutritional Science

Background:

• Neonatal jaundice is a common condition characterized by elevated bilirubin levels.
• Vitamin E, a potent antioxidant, plays a crucial role in cellular defense mechanisms.
• Investigating the therapeutic potential of Vitamin E for neonatal jaundice is of clinical interest.

Purpose of the Study:

• To evaluate the efficacy of oral Vitamin E in reducing bilirubin levels in premature neonates.
• To compare the effects of Vitamin E supplementation versus placebo on neonatal bilirubin concentrations.

Main Methods:

• A randomized clinical trial involving 100 premature neonates.
• Participants were divided into two groups: one receiving daily oral Vitamin E (10 units) for 5 days, and the other receiving a placebo.
• Bilirubin levels were measured at multiple time points: 0, 24, 48, 72, and 96 hours post-birth.

Main Results:

• Bilirubin levels initially increased in both groups but showed a decreasing trend earlier in the Vitamin E group (day 2) compared to the placebo group (day 3).
• While mean bilirubin increased significantly in both groups throughout the follow-up period, the average increase was lower in the Vitamin E group.
• On days 3 and 4, mean bilirubin levels were notably lower in neonates treated with Vitamin E.

Conclusions:

• Oral Vitamin E therapy demonstrates potential in reducing bilirubin levels in neonates.
• The beneficial effect of Vitamin E appears more pronounced after the third day of life.
• Neonates receiving Vitamin E supplementation exhibited lower bilirubin levels compared to the placebo group during follow-up.